Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
US9816074B2 · kind B2 · utility
5Cited by
48References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2015 |
| Grant date | Nov 14, 2017 |
| Priority date | — |
| Expiry date | Sep 8, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic stem cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.